Denali Therapeutics Inc. (20)

Browse by Contract Category

Contracts

Underwriting Agreement, dated as of October (Filed With SEC on October 20, 2022)
Amended and Restated Outside Director Compensation Policy (Filed With SEC on February 28, 2022)
Side Letter between the Registrant and F-star Gamma Limited, dated June 30, 2021 (Filed With SEC on August 4, 2021)
Amendment No. 5 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
Equity Distribution Agreement between the Company and Goldman Sachs & Co. LLC, SVB Securities LLC and Cantor Fitzgerald & Co., dated as of February 28, 2022 (Filed With SEC on February 28, 2022)
Description of the Registrants Common Stock (Filed With SEC on February 28, 2022)
Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 5, 2021)
Amendment No. 6 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October... (Filed With SEC on February 26, 2021)
Amended and Restated Outside Director Compensation Policy (Filed With SEC on February 26, 2021)
Description of the registrants common stock (Filed With SEC on February 26, 2021)
Form of Amended and Restated Change in Control and Severance Plan (Filed With SEC on November 5, 2020)
Definitive R (Filed With SEC on November 5, 2020)
Definitive LRRK2 Collaboration and License Agreement (Filed With SEC on November 5, 2020)
Standstill and Stock Restriction Agreement between the Registrant and Biogen Inc., dated September 22, 2020 (Filed With SEC on November 5, 2020)
Provisional LRRK2 Collaboration and License Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
Common Stock Purchase Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 7, 2020)
Description of the registrants common stock (Filed With SEC on February 27, 2020)
Underwriting Agreement, dated as of January 28, 2020, among Denali Therapeutics Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Jefferies LLC, as representatives... (Filed With SEC on January 29, 2020)